Rigel Pharmaceuticals Inc (NASDAQ:RIGL)

Delayed Data
As of Jun 30
 +0.115 / +11.17%
Today’s Change
Today|||52-Week Range

Stock Price Forecast

The 7 analysts offering 12-month price forecasts for Rigel Pharmaceuticals Inc have a median target of 1.00, with a high estimate of 7.00 and a low estimate of 0.80. The median estimate represents a -12.66% decrease from the last price of 1.15.

Analyst Recommendations

The current consensus among 7 polled investment analysts is to Hold stock in Rigel Pharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Hold rating.Move your mouse over past
months for detail


Earnings and Sales Forecasts

Current Quarter

Earnings per Share
Reporting Date
Aug 09

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 23.32%
Growthannually -377.05%


Growthquarterly 42.34%
Growthannually -41.58%
Key to the earnings and sales forecast charts.